Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum
about
Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline surveyDynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control studyLong-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivaxBaculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in miceAllele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovaleEstimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposureNaturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro modelNon-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposureTarget antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaAnalysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensAcquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseComparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic.Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infectionAcquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malariaCharacterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bondsPlasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individualsNaturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in CambodiaAntibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemiaAntibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India.Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.Role of cysteines in Plasmodium falciparum circumsporozoite protein: interactions with heparin can rejuvenate inactive protein mutants.Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia.Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection.
P2860
Q28345224-40B7BA20-3F70-4E0F-A5D1-6165C317DF65Q28608078-BAA196F2-EB9E-4CCB-B29B-5661DA510F41Q33278087-6520C20A-145C-4627-B96F-21D553CB10D4Q33344450-CCC22071-B3DB-459F-AF7F-F4EA837075EDQ33533328-07160B32-91D3-49B8-9380-C85001752526Q33613859-8BE5704F-F7BE-4584-910A-94468B0C85EEQ33653151-6E63CBC5-B203-440D-A920-A910A1291A42Q33866742-13725E42-1D6B-4CE7-BAAA-2542B0220DCDQ33880777-7A0F02DC-7C81-4002-9F7A-DFDF11DB1D85Q33935818-42487719-AAE4-4F21-9779-1AD01B200886Q34008262-A4383988-6B5C-429E-B7E1-D973061A3F4BQ34047037-4381F2D6-6259-4913-BDCB-984BD26291FAQ34123317-1CBD8189-C9A4-440B-8B6A-2224F1996C27Q34154429-AC0F0657-2868-4345-AFC6-DFDB3671828FQ34257253-BEF74778-4D9F-4E15-B8CE-42EFE46B2739Q34301187-1F98ED8C-17A7-4E3D-B8F0-F35391706966Q34334187-A9B3688A-C684-4AD0-8684-9A11EEE128F4Q34778078-AC934263-56F3-425F-AB85-B1F7B4BD22ACQ34955461-3C70BF0B-4D33-443A-AD3C-FBB5C0C63373Q35194707-EA30A9AF-B352-45B2-8489-AEE2F905871EQ35241288-945667C2-6A42-4F02-A4F8-A0051619B629Q35444728-D9A10095-6CA4-4E05-B2E0-1E68AAE240C8Q35505807-6D11D42F-2B06-44F1-8136-07A18C740910Q35516848-88EA689F-C40C-46BE-8BCC-B6FDE5D05EC6Q35546112-C0E32811-41B1-4BE1-835C-7D2732AF51E9Q35551944-0671A658-4810-43AE-ABB5-EFF1F7C9CA1AQ35762375-2E34C73C-02B3-4B95-8550-748BF633D22CQ35901099-ABAB40BF-FEFA-4E03-AA14-453C8D6FAE42Q35964846-0DD15B14-1FBC-4B77-B4ED-6FCED3B05B23Q36005592-70D8A936-0581-4745-B6C1-91D8724B462FQ36368911-CC3FBD0C-79C9-4CB7-9601-7D2724529E61Q36576319-3257D5A4-AB88-4257-9FA2-F68E5A3FCFC9Q36800846-10E8D6A6-2A08-442B-ADF2-9935D0D75CC4Q37099503-143E655A-9B57-4CF9-A087-AEF5CE127EB7Q37232082-B1F3E4DC-AE4C-419A-87A5-AFC56A9B0B28Q37313879-0313735C-6CD1-4DC8-937A-D1FDE98BD0FEQ37523653-D6B0540C-6DBE-4C61-9A6C-38E61D026866Q37523881-AE4F9369-F06F-458D-86A7-86C8FB80BFE4Q37523989-2CD3A5AF-757B-41D2-8727-61DA6AF3E94BQ37566118-F9BB09C8-FAA6-41F2-BF2B-95E267BDF38D
P2860
Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@ast
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@en
type
label
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@ast
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@en
prefLabel
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@ast
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@en
P2093
P2860
P921
P1476
Serum antibodies from malaria- ...... otein of Plasmodium falciparum
@en
P2093
A A Holder
D C Kaslow
J A Chappel
J S McBride
J S Morris
P A Burghaus
P2860
P304
P407
P577
1995-02-01T00:00:00Z